Fleury S.A.

Equities

FLRY3

BRFLRYACNOR5

Healthcare Facilities & Services

Market Closed - Sao Paulo Other stock markets 04:07:52 2024-04-26 pm EDT			5-day change	1st Jan Change
14.61 ^BRL	+4.28%		+4.06%	-19.01%

Mar. 08	Transcript : Fleury S.A., Q4 2023 Earnings Call, Mar 08, 2024
Mar. 07	Fleury S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Fleury S.A. completed the acquisition of Methodos laboratory in Minas Gerais.

October 03, 2022

Fleury S.A. (BOVESPA:FLRY3) acquired Methodos laboratory in Minas Gerais for BRL 27.4 million on October 3, 2022.

Fleury S.A. (BOVESPA:FLRY3) completed the acquisition of Methodos laboratory in Minas Gerais on October 3, 2022.

Latest news about Fleury S.A.

Transcript : Fleury S.A., Q4 2023 Earnings Call, Mar 08, 2024	Mar. 08
Fleury S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 07	CI
Fleury S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
Fleury S.A Seeks Inorganic Growth	Nov. 10	CI
Transcript : Fleury S.A., Q3 2023 Earnings Call, Nov 10, 2023	Nov. 10
Fleury S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
Fleury Seeks Inorganic Growth	23-08-04	CI
Transcript : Fleury S.A., Q2 2023 Earnings Call, Aug 04, 2023	23-08-04
Fleury S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-02	CI
Transcript : Fleury S.A., Q1 2023 Earnings Call, May 05, 2023	23-05-05
Fleury S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-03	CI
Fleury S.A. completed the acquisition of Instituto Hermes Pardini S.A. from Pardini family and others.	23-04-27	CI
Transcript : Fleury S.A., Q4 2022 Earnings Call, Mar 17, 2023	23-03-17
Fleury S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-16	CI
Transcript : Fleury S.A., Q3 2022 Earnings Call, Nov 04, 2022	22-11-04
Fleury S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-03	CI
Brazil's Fleury gets green light for capital increase of up to $229 mln	22-10-17	RE
Brazil's Fleury gets green light for capital increase of up to $229 mln	22-10-17	RE
Fleury S.A. completed the acquisition of Methodos laboratory in Minas Gerais.	22-10-03	CI
C2N Diagnostics LLC Partners with Grupo Fleury to Bring Pioneering Blood Tests to Brazil for Advancing Brain Health	22-09-21	CI
Transcript : Fleury S.A., Q2 2022 Earnings Call, Aug 05, 2022	22-08-05
Fleury S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-04	CI
Brazil's freight platform Frete.com to spend $55 mln on M&A -CEO	22-07-06	RE
Transcript : Fleury S.A., Instituto Hermes Pardini S.A. - M&A Call	22-06-30
Transcript : Fleury S.A., Instituto Hermes Pardini S.A. - M&A Call	22-06-30

Chart Fleury S.A.

Duration

Period

More charts

Company Profile

Fleury S.A. specializes in clinical diagnosis, treatment and analysis services. At the end of 2018, the group operated a network of 187 patient care centers and 23 hospital centers under Fleury, Weinmann, Clínica Felipe Mattoso, a +, Labs a + and Diagnoson a + brands.

Sector

Healthcare Facilities & Services

Calendar

2024-05-08 - Q1 2024 Earnings Release

Related indices

BRAZIL IBOVESPA

More about the company

Income Statement Evolution

More financial data

Ratings for Fleury S.A.

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

14.61 BRL

Average target price

19.9 BRL

Spread / Average Target

+36.21%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
FLEURY S.A.	-19.01%	1.55B
SONIC HEALTHCARE LIMITED	-17.89%	8.25B
RADNET, INC.	+39.20%	3.57B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-39.11%	2.46B
SYNLAB AG	-8.06%	2.46B
DR. LAL PATHLABS LIMITED	-7.35%	2.38B
NEOGENOMICS, INC.	-12.61%	1.81B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.66%	1.21B
METROPOLIS HEALTHCARE LIMITED	+7.56%	1.11B
ADICON HOLDINGS LIMITED	-15.34%	1.03B

Medical & Diagnostic Laboratories